skinny.

Latest / The Bell2Bell (B2B) Podcast

Bell2Bell Podcast featuring Clene Inc. CEO Rob Etherington

Bell2Bell’s latest podcast features Rob Etherington, President and CEO of Clene Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases.

To begin the interview, Etherington provided an introduction to Clene’s business model and discussed recent developments providing hope to those affected by neurodegenerative conditions.

“Clene spends every waking moment working on amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative condition. We are focused on neurodegenerative…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.